Mark Roest (M Roest)

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 4

Top Topics

Angiotensin Converting Enzyme

Chronic Kidney Disease

Ejection Fraction

Patient Reported Outcomes

Top Venues

International journal of laboratory hematology

Journal of thrombosis and haemostasis : JTH

University Medical Center Utrecht (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University Medical Center Utrecht Nov 01 1995 - Nov 21 1999

Netherlands

PHD :: Thrombosis and Haemostasis

Publications

Jinmi Zou, Jiayu Wu, Mark Roest, Johan W M Heemskerk
Long-term platelet priming after glycoprotein VI stimulation in comparison to Protease-Activating Receptor (PAR) stimulation. PloS one 16 (3) (2021)
Wariya Sanrattana, Simone Smits, Arjan D Barendrecht, Nadine D van Kleef, Hinde El Otmani, Minka Zivkovic, Mark Roest, Thomas Renne, Chantal C Clark, Steven de Maat, Coen Maas
Targeted SERPIN (TaSER): A dual-action antithrombotic agent that targets platelets for SERPIN delivery. Journal of thrombosis and haemostasis : JTH (2021)
Li Li, Dana Huskens, Lisa Florin, Bas de Laat, Mark Roest, Katrien M J Devreese
Flow cytometric analysis of platelet function to detect high on-treatment residual platelet reactivity in patients on dual antiplatelet therapy. International journal of laboratory hematology (2021)
H P Eising, Mark Roest, P G de Groot, D Huskens, J Konings, R T Urbanus, B de Laat, J A Remijn
High prevalence of reduced thrombin generation and/or decreased platelet response in women with unexplained heavy menstrual bleeding. International journal of laboratory hematology 40 (3) (2018)